Hypermarcas (OTCMKTS:HYPMY) Trading 8.9% Higher – Here’s Why

Hypermarcas (OTCMKTS:HYPMY)’s share price traded up 8.9% during trading on Thursday . The stock traded as high as $4.67 and last traded at $4.67. 1,391 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 3,110 shares. The stock had previously closed at $4.2896.

Hypermarcas Stock Performance

The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The firm’s fifty day moving average price is $4.52 and its 200-day moving average price is $4.45. The firm has a market cap of $3.05 billion, a price-to-earnings ratio of 20.91 and a beta of 0.72.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%. The company had revenue of $408.83 million during the quarter.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.